How Our Microbiome Influences Immunotherapy Response and Toxicity and Is Now A Therapeutic Target In Its Own Right · Dr Trevor LawleyWelcome and introduction · Dr Mark Harries
Surgery for Peritoneal Metastases: Current Trends and Future Evolution; Microbiome Matters: Understanding its Role in Colorectal Cancer; Obesity, GLP-1 Agonists and Cancer Outcomes · Professor Omer Aziz (first talk)New and Emerging Therapies; Academic Clinical Trials in CRC; Managing Toxicity in Immunotherapy · Professor Richard Wilson; Professor Rob Jones; Dr Christopher Williams; Professor Tim Cooksley